Lingual necrosis caused by mucormycosis in a patient with aplastic anaemia: case report.

[1]  G. Petrikkos,et al.  Global epidemiology of cutaneous zygomycosis. , 2012, Clinics in dermatology.

[2]  B. Spellberg,et al.  Pathogenesis of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Kontoyiannis,et al.  Epidemiology and clinical manifestations of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  B. Spellberg,et al.  Combination therapy for mucormycosis: why, what, and how? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Thomas R Rogers,et al.  Treatment of zygomycosis: current and new options. , 2008, The Journal of antimicrobial chemotherapy.

[6]  Brad Spellberg,et al.  Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management , 2005, Clinical Microbiology Reviews.

[7]  T. Walsh,et al.  Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. , 2005, The Journal of infectious diseases.

[8]  J. Ribes,et al.  Zygomycetes in human disease. , 2000, Clinical microbiology reviews.

[9]  E. Grossman.  Cutaneous Manifestations of Infection in the Immunocompromised Host , 1995 .